Source comparison
Tesamorelin + Ipamorelin Blend with Alcohol Safety: Comparison
Alcohol 24h before peptide dose 1–2 standard drinks consumed 24h prior Low. Ethanol cleared, acute suppression resolved Minimal. GH pulse amplitude restored to baseline No additional recovery needed Safe when occasional; not sustainable if frequent Alcohol 12h
This comparison does not assign a generated winner or score.
- Alcohol 24h before peptide dose
- 1–2 standard drinks consumed 24h prior
- Low. Ethanol cleared, acute suppression resolved
- Minimal. GH pulse amplitude restored to baseline
- No additional recovery needed
- Safe when occasional; not sustainable if frequent
- Alcohol 12h before peptide dose
- 2–3 drinks consumed evening before morning dose
- Moderate. Residual acetaldehyde, partial HPA activation
- Significant. 30–50% reduction in peptide-induced GH pulse
- 24h abstinence recommended before next dose
- Alcohol 6h before peptide dose
- 2+ drinks consumed same day as evening peptide dose
- High. Active ethanol metabolism, peak cortisol elevation
- Severe. 60–80% blunting of peptide efficacy
- 36–48h abstinence to restore baseline GH response
- Not recommended. Metabolically counterproductive
- Chronic moderate drinking (7+ drinks/week)
- Ongoing alcohol intake throughout peptide cycle
- Sustained. Chronic suppression of GH-IGF-1 axis
- Critical. Peptide outcomes diminished regardless of timing
- Requires 2+ weeks abstinence to restore hepatic IGF-1 synthesis
- Incompatible with therapeutic peptide protocols